LYKA LABS
Back to Income Statement
|
LYKA LABS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹-10 Cr | ₹8.01 Cr | ₹-2.49 Cr | ₹-13 Cr | ₹39 Cr |
What is the latest Consolidated Net Profit of LYKA LABS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹-10 Cr |
| Mar2025 | ₹8.01 Cr |
| Mar2024 | ₹-2.49 Cr |
| Mar2023 | ₹-13 Cr |
| Mar2022 | ₹39 Cr |
How is Consolidated Net Profit of LYKA LABS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹-10 Cr | Negative | |
| Mar2025 | ₹8.01 Cr | Positive | |
| Mar2024 | ₹-2.49 Cr | Negative | |
| Mar2023 | ₹-13 Cr | Negative | |
| Mar2022 | ₹39 Cr | - | |
Compare Consolidated Net Profit of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹265.9 Cr | 8.2% | 16.4% | -29.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,090.0 Cr | 1% | -2.7% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,976.0 Cr | 0.7% | 17.1% | 40.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,639.0 Cr | -0.3% | -3.7% | 37.9% | Stock Analytics | |
| CIPLA | ₹115,216.0 Cr | -0.3% | 2.3% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | -1.4% | 0.7% | -6.2% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | 8.2% |
16.4% |
-29.1% |
| SENSEX | -0.6% |
1% |
-3.7% |
You may also like the below Video Courses